Could a probiotic help prevent gut scarring in Crohn's disease?
NCT ID NCT07263880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether a probiotic called Clostridium butyricum can help prevent or treat scarring in the gut caused by Crohn's disease. About 40 adults with a narrowing form of Crohn's will take the probiotic, a sugar called trehalose, both, or a placebo for two months before a colonoscopy. Researchers will check tissue and blood samples for signs of reduced inflammation and scarring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
San Giovanni Addolorata Hospital
Roma, 00184, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
- Can better detection of precancerous lesions in IBD prevent colorectal cancer?
- Which biologic best stops Crohn's from coming back after surgery?
- New biologic mirikizumab put to the test against standard therapies for IBD
- Blood and stool tests could revolutionize IBD monitoring